Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xex991.htm |
| EX-99.3 - EXHIBIT 99.3 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xex993.htm |
| EX-32.1 - EXHIBIT 32.1 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xexx321.htm |
| EX-99.2 - EXHIBIT 99.2 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xex992.htm |
| EX-99.4 - EXHIBIT 99.4 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xex994.htm |
| EX-32.2 - EXHIBIT 32.2 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xexx322.htm |
| EX-31.1 - EXHIBIT 31.1 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xexx311.htm |
| EX-31.2 - EXHIBIT 31.2 - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630xexx312.htm |
| 10-Q - 10-Q - INTEGRA LIFESCIENCES HOLDINGS CORP | iart-20150630x10q.htm |
Exhibit 23.1
Consent of Independent Auditors |
We consent to the use of our report dated June 25, 2015, with respect to the consolidated financial statements of TEI Biosciences Inc. and Subsidiary included as Exhibit 99.3 of Integra Lifesciences Holdings Corporation’s Form 10-Q for the period ended June 30, 2015. |
/s/ Ernst and Young LLP Boston, MA July 31, 2015 |